InMed Pharmaceuticals Inc.INMNASDAQ
Loading
Revenue PerformanceStrong
Percentile Rank100
3Y CAGR+65.5%
Studio
Year-over-Year Change

Total revenue from sales of goods and services

3Y CAGR
+65.5%/yr
Annual compound
Percentile
P100
Near historical high
vs 3Y Ago
4.5x
Strong expansion
Streak
4 yr
Consecutive growthStrong
PeriodValueYoY Change
2025$4.94M+7.5%
2024$4.60M+11.2%
2023$4.14M+279.6%
2022$1.09M-
2021$0.00-
2020$0.00-
2019$0.00-
2018$0.00-
2017$0.00-
2016$0.00-